Hannah Valantine, Director at CareDx, Inc. (CDNA), sold 12,103 shares at $23.11 ($280K) on 2026-06-15, disclosed to the SEC on 2026-06-16.
Scheduled sale ($280k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BBIO | SELL | 2026-03-12 | $624K | — | Filing → |
| BBIO | SELL | 2026-03-03 | $1.7M | — | Filing → |
| BBIO | SELL | 2025-11-14 | $3.4M | — | Filing → |